New drug aims to save premature babies' eyesight
Disease control
Recruiting now
This early-stage study tests a new medicine called FLQ-101 in 18 premature babies born at 26-27 weeks who are at high risk for retinopathy of prematurity (ROP), an eye disease that can cause blindness. The main goal is to check the drug's safety and how the body processes it. Res…
Phase: PHASE1 • Sponsor: FELIQS INC. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC